Post Profile

Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy

SEOUL (Reuters) - A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.
read more

See more about: South Korea

Related Posts

South Korea says to file suit against VW's local chief in emissions case

Issues & Causes / Environmentalism : Reuters Environment Blog

SEOUL (Reuters) - South Korea's environment ministry said it plans to file a criminal complaint later on Tuesday against the head of the South Korean unit of Volkswagen AG and Audi AG over an emissions test cheating scandal.

Nissan sues South Korea government over accusations of emissions cheating

Issues & Causes / Environmentalism : Reuters Environment Blog

SEOUL (Reuters) - Nissan Motor Co Ltd's South Korean unit said it has filed a lawsuit over claims by the government that the automaker had cheated on emissions with its Qashqai diesel sport utility vehicle.

Samsung Bioepis seeks Europe approval for its Herceptin copy

Health : Reuters: Health

SEOUL (Reuters) - Biosimilars maker Samsung Bioepis, part of South Korea's top conglomerate Samsung Group [SAGR.UL], said on Tuesday it is seeking regulatory approval in Europe to sell its copy of Roche's breast cancer drug Hercepti...

Samsung Bioepis receives final European approval for its Remicade copy

Business & Finance : Business Insider: Clusterstock

SEOUL (Reuters) - South Korea's Samsung Bioepis said on Monday its biosimilar of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade has received final approval from European regulators, paving the way for its second ...

FDA approves Samsung Bioepis' copy of J&J's Remicade: company

Health : Reuters: Health

SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson & Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group...


Copyright © 2016 Regator, LLC